ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

639
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•07 Dec 2020 20:41

The Stocks to Own in Asia – Vol. 31

The Stocks to Own in Asia – Vol. 31. We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology.

Share
bullish•Quantitative Analysis
•05 Dec 2020 04:49

Asia Short Interest: Sinopec, Kingdee, Anta, Recruit, Capcom, Sharp, Celltrion, Samsung, Delta, TSMC

The Short Interest report looks at large weekly movements across HK, Japan, Korea and Taiwan. Ping An saw a huge increase in shorts while TSMC saw...

Logo
447 Views
Share
bullish•Abbott Laboratories
•30 Nov 2020 19:43

Biden COVID-19 Response Plan: Overview of Its Inherent Investment Themes

Biden's recently-announced COVID-19 response plan suggests a number of investment themes. This Insight overviews the more significant of those...

Logo
286 Views
Share
bearish•Quantitative Analysis
•28 Nov 2020 04:35

Asia Short Interest Weekly: Tencent, Want Want, Showa Denko, NBF, LG Chem, AmoreCorp, Pegatron

The Asia short report highlights large movements in weekly short interest across HK, Japan, Korea and Taiwan to be used as an input in trading...

Logo
367 Views
Share
bearish•Quantitative Analysis
•14 Nov 2020 08:05

Asia Short Interest Weekly: Shorts Continue to Rise in HK, Japan & Taiwan; Korea Ban to Be Lifted

Short interest continued to increase in HK, Japan and Taiwan, while the FSC has announced that the short sell ban in Korea will be lifted on 15...

Logo
474 Views
Share
x